Autoimmune diagnostics

Limbach Gruppe offer more than 200 established clinical markers for targeted diagnosis of systemic and organ-specific autoimmune diseases. We continually expand our portfolio, adding new medically relevant target antigens and diagnostic autoantibodies. Given the vast number of available markers, it is particularly important to choose suitable test systems and ensure skilled result assessment. Our experts at Limbach Gruppe will provide customised assistance to ensure a rational and systematic diagnostic approach.

Our core services in autoimmune diagnostics

• Wide range of autoimmune diagnostic methods, including indirect immunofluorescence testing (IFT), ELISA, Western blot, line blot, immunoprecipitation, and other methods
• Full autoantibody testing, both for common and rare autoimmune diseases
• Laboratory diagnostics for confirmation of systemic autoimmune diseases such as rheumatoid arthritis, collagenosis, antiphospholipid syndrome, ANCA-associated vasculitis
• Laboratory diagnostics for confirmation of autoantibodies in organ-specific autoimmune diseases involving the stomach, intestines, liver, pancreas, heart, kidney, lungs, skin, thyroid gland, adrenal gland, nervous system or muscles
• Detection of autoantibodies associated with immune-mediated inflammatory diseases such as coeliac disease
• Detection of autoantibodies associated with paraneoplastic syndromes
• Detection of autoantibodies in type 1 diabetes mellitus and/or LADA (late onset autoimmune diabetes)
• Step-by-step diagnostic approaches taking account of the sensitivity and specificity of the diagnostic test systems
• Early analytics and assessments, also for rarely requested parameters
• Development of own tests to complete the service portfolio